At a glance
- Originator QLT USA
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Cell membrane permeability inhibitors; Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postoperative pain
Most Recent Events
- 17 Aug 2006 Discontinued - Phase-I for Postoperative pain in USA (Injection)
- 22 Nov 2004 Atrix Laboratories has been acquired by QLT
- 24 May 2001 Phase-I clinical trials for Postoperative pain in USA (Injection)